Nova Leap Health Corp. NLH.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.39M | 7.85M | 8.09M | 8.26M | 8.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.39M | 7.85M | 8.09M | 8.26M | 8.02M |
| Cost of Revenue | 5.61M | 4.72M | 4.87M | 4.99M | 4.80M |
| Gross Profit | 3.79M | 3.13M | 3.22M | 3.27M | 3.22M |
| SG&A Expenses | 2.85M | 2.69M | 2.76M | 2.62M | 2.66M |
| Depreciation & Amortization | 178.80K | 148.80K | 194.00K | 233.40K | 208.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.64M | 7.56M | 7.83M | 7.85M | 7.67M |
| Operating Income | 754.70K | 291.20K | 261.90K | 418.60K | 350.40K |
| Income Before Tax | 882.90K | 455.10K | -63.90K | 586.90K | -578.50K |
| Income Tax Expenses | 232.90K | 130.50K | -10.20K | 160.70K | -94.50K |
| Earnings from Continuing Operations | 650.00K | 324.60K | -53.70K | 426.20K | -484.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 650.00K | 324.60K | -53.70K | 426.20K | -484.00K |
| EBIT | 754.70K | 291.20K | 261.90K | 418.60K | 350.40K |
| EBITDA | 933.40K | 440.10K | 383.70K | 652.00K | 559.30K |
| EPS Basic | 0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 87.31M | 87.31M | 90.63M | 87.31M | 87.31M |
| Average Diluted Shares Outstanding | 88.27M | 88.00M | 90.63M | 87.95M | 87.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |